Who is sponsoring NCT04904939?

NCT04904939 is sponsored by Alexandria University.

What drugs are being tested in NCT04904939?

Interventions in NCT04904939: Bronchoscopic mucosal biopsy.

What condition does NCT04904939 study?

NCT04904939 studies Endobronchial Mucosal Pathology in Pulmonary Sarcoidosis.

Is NCT04904939 still recruiting?

NCT04904939 is currently completed. Last updated 27 May 2021.

Last reviewed 2021-05-27 · How we verify

NCT04904939

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Endobronchial Mucosal Biopsy in Patients With Suspected Pulmonary Sarcoidosis

Completed NA Last updated 27 May 2021

What this trial tests

NA trial testing Bronchoscopic mucosal biopsy in Endobronchial Mucosal Pathology in Pulmonary Sarcoidosis in 20 participants. Completed in 28 September 2020.

Timeline

15 May 2020

Primary endpoint
1 September 2020

28 September 2020

Quick facts

Lead sponsor	Alexandria University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	single
Primary purpose	diagnostic
Enrollment	20
Start date	15 May 2020
Primary completion	1 September 2020
Estimated completion	28 September 2020
Sites	1 location across Egypt

Drugs / interventions tested

Bronchoscopic mucosal biopsy

Conditions studied

Endobronchial Mucosal Pathology in Pulmonary Sarcoidosis — all drugs for Endobronchial Mucosal Pathology in Pulmonary Sarcoidosis →

Sponsor

Alexandria University

Who can join

18 and older, any sex, with Endobronchial Mucosal Pathology in Pulmonary Sarcoidosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective interventional study was done between May and September 2020. We included 20 patients from the chest department, Alexandria Main University Hospital (AMUH) with the inclusion criteria of having suspected pulmonary sarcoidosis (based on clinical and radiological presentation) and being ≥18 years of age. The bronchoscopy procedure was done under local anesthesia. Endobronchial biopsies and bronchoalveolar lavage were obtained.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Alexandria University trials

Trials by the same sponsor.

NCT07517861 — Integrated Mental Health Nursing Program: Effects on Stigma, Cognitive Flexibility, and Clinical Readiness · NA · recruiting
NCT07476482 — The Impact of a Shared Decision-Making Intervention on Intraoperative Patient Experience During Elective Cesarean Delive · NA · enrolling by invitation
NCT07476209 — Sialendoscopy Versus Photobiomodulation in Prevention of Radiation Induced Xerostomia · NA · recruiting
NCT07503626 — Optimization of Orthodontic Bracket Placement by Using Two Different Protocols of Digitally Aided Bonding · NA · recruiting
NCT07522944 — AI-Guided Relaxation for Hemodialysis Anxiety · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04904939 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Alexandria University
Last refreshed: 27 May 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04904939.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing